These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1352697)

  • 1. Caring for the cancer patient: managing emesis now. An interactive workshop. Proceedings of a satellite symposium to the 6th European Conference on Clinical Oncology. Florence, October 1991.
    Eur J Cancer; 1992; 28A Suppl 1():S1-44. PubMed ID: 1352697
    [No Abstract]   [Full Text] [Related]  

  • 2. Are granisetron and ondansetron equivalent in the clinic?
    Dilly S
    Eur J Cancer; 1992; 28A Suppl 1():S32-5. PubMed ID: 1320918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and Management of Nausea and Emesis Associated with Cancer Therapy. Symposium proceedings. Marlow, United Kingdom, October 13-14, 1994.
    Oncology; 1996 Jun; 53 Suppl 1():1-110. PubMed ID: 8692543
    [No Abstract]   [Full Text] [Related]  

  • 4. BRL 43694: a novel antiemetic to prevent nausea and vomiting induced by chemotherapy.
    Joss RA; Richner J; Brunner KW; Rohrbach D; Pirovino M; Terrey JP; Upward J
    J Natl Cancer Inst; 1988 Oct; 80(16):1340-1. PubMed ID: 2845107
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.
    Bots MW; Dijkstra HJ; Blijham GH; van der Wall E; Fehmers MC; Keizer HJ; Nortier JW; Siegenbeek van Heukelom L; Slee PH; Veenhof CH
    Neth J Med; 1992 Jun; 40(5-6):221-6. PubMed ID: 1331830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Addelman M; Erlichman C; Fine S; Warr D; Murray C
    J Clin Oncol; 1990 Feb; 8(2):337-41. PubMed ID: 2153767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastrointestinal side effects of anticancer agents and their counter measures].
    Nakao I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):928-30. PubMed ID: 2160800
    [No Abstract]   [Full Text] [Related]  

  • 8. Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.
    Plosker GL; Goa KL
    Drugs; 1991 Nov; 42(5):805-24. PubMed ID: 1723376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.
    Ettinger DS
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):6-18. PubMed ID: 7570053
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms and management of nausea and emesis.
    Dicato M
    Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
    [No Abstract]   [Full Text] [Related]  

  • 11. Tropisetron and the 5-HT3 Antiemetics in Perspective. Proceedings of an international symposium. Vienna, Austria, October 2, 1992.
    Ann Oncol; 1993; 4 Suppl 3():1-47. PubMed ID: 8103353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
    Matsuishi H; Harada M; Gondo H; Otsuka T; Teshima T; Yamano Y; Omori F; Shibuya T; Yamazaki K; Taniguchi S
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1339-48. PubMed ID: 8394061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: a summary.
    Pintens H
    Cancer Treat Rev; 1990 Sep; 17(2-3):307-10. PubMed ID: 2176932
    [No Abstract]   [Full Text] [Related]  

  • 14. [The prevention of CDDP-induced emesis with granisetron].
    Fukunaka N; Sagae S; Kitajima Y; Ishioka S; Sato K; Itoh E; Kudo R
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1101-5. PubMed ID: 8390228
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of cytostatic drug-induced emesis. Proceedings of an official satellite symposium to the 5th European Conference on Clinical Oncology (ECCO5). London, September 1989.
    Eur J Cancer; 1990; 26 Suppl 1():S1-44. PubMed ID: 1976326
    [No Abstract]   [Full Text] [Related]  

  • 16. Fighting nausea in the '90s: more and better anti-emetics can help.
    Saphir A
    J Natl Cancer Inst; 1997 Sep; 89(17):1252-5. PubMed ID: 9293911
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
    Takahashi T; Mori K; Suga Y; Tominaga K
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1873-5. PubMed ID: 8397491
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
    Hsu ES
    Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-emetics in oncology].
    Mahjoubi M; Lopez C; Pallard MC; Droz JP
    Rev Infirm; 1990 Dec; 40(19):35-7. PubMed ID: 2091208
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.